Filing Details
- Accession Number:
- 0001140361-17-001375
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-10 16:50:32
- Reporting Period:
- 2017-01-09
- Filing Date:
- 2017-01-10
- Accepted Time:
- 2017-01-10 16:50:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238403 | K Daniel Spiegelman | C/O Biomarin Pharmaceutical Inc., 770 Lindaro St. San Rafael CA 94901 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-01-09 | 5,000 | $90.00 | 18,100 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on November 16, 2016.
- All shares were sold at the same price.
Billionaire Hedge Funds
